MA42973A - Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis - Google Patents

Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis

Info

Publication number
MA42973A
MA42973A MA042973A MA42973A MA42973A MA 42973 A MA42973 A MA 42973A MA 042973 A MA042973 A MA 042973A MA 42973 A MA42973 A MA 42973A MA 42973 A MA42973 A MA 42973A
Authority
MA
Morocco
Prior art keywords
hyperimmunity
personalized
psoriasis
manufacture
treatment
Prior art date
Application number
MA042973A
Other languages
English (en)
Inventor
Chiurciu Constantin
Victor Patrascu Ionel
Iuliana Mihai
Lucica Sima
Chiurciu Viorica
Original Assignee
Romvac Company Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romvac Company Sa filed Critical Romvac Company Sa
Publication of MA42973A publication Critical patent/MA42973A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MA042973A 2015-10-16 2016-01-08 Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis MA42973A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201500735A RO130965A8 (ro) 2015-10-16 2015-10-16 Producerea şi utilizarea oului hiperimun personalizat () în tratamentul psoriazisului

Publications (1)

Publication Number Publication Date
MA42973A true MA42973A (fr) 2018-08-22

Family

ID=55754390

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042973A MA42973A (fr) 2015-10-16 2016-01-08 Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis

Country Status (4)

Country Link
EP (1) EP3362092A1 (fr)
MA (1) MA42973A (fr)
RO (1) RO130965A8 (fr)
WO (1) WO2017065626A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO132299A3 (ro) * 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()
US11319382B1 (en) 2021-06-28 2022-05-03 King Abdulaziz University Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068524C (zh) * 1997-06-23 2001-07-18 叶庆炜 一种治疗顽症牛皮癣的药物
JP2002509109A (ja) * 1998-01-19 2002-03-26 ディーシーヴィー インコーポレイテッド 関節炎および／または自己免疫疾患を治療および予防するための組成物および方法
CN1331700A (zh) * 1998-11-16 2002-01-16 基因纬生物技术公司 通过禽类中使用多核苷酸疫苗接种生成抗体的方法
NZ575918A (en) * 2006-08-31 2012-03-30 A C N 135 493 391 Pty Ltd As Trustee For Conca Unit Trust Treatment and/or prevention of non-infectious medical conditions using antibody-containing milk or egg products
CN101790540A (zh) * 2007-08-30 2010-07-28 本特·阿格鲁普 局部施用鸡卵黄免疫球蛋白(IgY)以治疗和预防真菌感染
JP5439127B2 (ja) * 2009-11-13 2014-03-12 株式会社さいわいメディカル 乾癬又はアトピー性皮膚炎治療剤
RO129645B1 (ro) * 2014-02-25 2022-05-30 Romvac Company S.A. PROCEDEU DE OBŢINERE A IMUNOGLO- BULINELOR IgY
RO130213A8 (ro) * 2014-10-29 2017-06-30 Romvac Company S.A. Producerea şi folosirea oului hiperimun - pc2

Also Published As

Publication number Publication date
RO130965A8 (ro) 2017-06-30
EP3362092A1 (fr) 2018-08-22
WO2017065626A1 (fr) 2017-04-20
RO130965A0 (ro) 2016-03-30

Similar Documents

Publication Publication Date Title
DK3743053T3 (da) Anvendelse af cannabinoider i behandling af epilepsi
MA45192A (fr) Traitement d'association
DK3641819T3 (da) Anvendelse af cannabidiol i behandling af tuberøst sklerosekompleks
DK3334422T3 (da) Anvendelse af cannabidiolsyre i behandling af epilepsi
MA42819A (fr) Procédés pour le traitement d'infections virales à arenaviridae et coronaviridae
MA39960A (fr) Composés imidazo[4,5c]quinoline-2-one et leur utilisation dans le traitement du cancer
DK3313401T3 (da) Nanopartikler omfattende sirolimus og albumin til anvendelse i behandling af epithelioide celletumorer
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
MA40008A (fr) Antagoniste actrii pour le traitement et la prevention d'un ulcere cutane chez un sujet ayant l'anemie
DK3432899T3 (da) Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
DK3562486T3 (da) Anvendelse af sublingual dexmedetomidin til behandling af agitation
MA47450A (fr) Sulfinylpyridines et leur utilisation dans le traitement du cancer
DK2945642T3 (da) Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme
DK3532067T3 (da) Liposomal formulering til anvendelse til behandling af cancer
DK3391902T3 (da) Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati
MA44762A (fr) Sémaglutide utilisé dans le traitement de maladies cardiovasculaires
FR3022917B1 (fr) Materiau d'electrode et son utilisation pour la fabrication d'anode inerte
MA42915A (fr) Pyridines et leur utilisation dans le traitement du cancer
DK3423060T3 (da) Imatinib til anvendelse til behandling af slagtilfælde
DK3541961T3 (da) Streptococcus thermophilus til anvendelse i fremstilling af fermenterede produkter
DK3386916T3 (da) Forbedringer i produktionen af silicium-nanopartikler og anvendelser deraf
DK3440752T3 (da) Indsatshalvdel og indsatsblok omfattende to af nævnte indsatshalvdele
MA42973A (fr) Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis
MA39912A (fr) Dérivés de 2-aryl-4-hydroxy-1,3-thiazole comme antagonistes du trpm8, et leur utilisation dans le traitement de la neuralgie, de la douleur, de la bpco et de l'asthme.